ENDLOS-TURBO PUT - AMGEN | Delayed Deutsche Boerse AG 12:35:19 2024-06-12 pm EDT | ||
| 4.73 EUR | -0.63% |
|
| Current month | +7.21% | ||
| 1 month | +20.51% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-12 | 4.73 | -0.63% |
| 24-06-11 | 4.76 | +6.97% |
| 24-06-10 | 4.45 | +2.77% |
| 24-06-07 | 4.33 | +4.09% |
| 24-06-06 | 4.16 | +1.71% |
Delayed Quote Deutsche Boerse AG
Last update June 12, 2024 at 12:35 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ258D |
| ISIN | DE000DJ258D5 |
| Date issued | 2023-10-13 |
| Strike | 351.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.677 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.96 € |
|---|---|
| Lowest since issue | 2.56 € |
| Spread | 0.02 € |
| Spread % | 0.42% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
300.7
USD
Average target price
316.3
USD
Spread / Average Target
+5.18%
- Stock Market
- Certificates
- Certificat
